Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : IFMX - Investment Discussion -- Ignore unavailable to you. Want to Upgrade?

To: Dave Yenne who wrote (10780)	5/13/1998 11:36:00 AM
From: Mark Finger	Read Replies (2) \| Respond to of 14631

>>Michelle, I knew that IFMX made deal with Fletcher to raise capital, >>but I didn't know the details. The Fletcher deal was not the only deal done to raise cash. The following are SEC filings: First, a summary of everything (S-1 filed 1/9/98): sec.gov from page 7: >>The Company raised aggregate net proceeds of $37.2 million in August >>1997 and $48.8 million in November 1997 in separate financing >>transactions in which the Company issued newly authorized series of >>convertible Preferred Stock. In the fourth quarter of 1997, the >>Company raised aggregate net proceeds of $58.1 million through the >>sale of real property it had purchased earlier in the year. The 8-K (12/04/97) concerning Credit Suisse First Boston in the November transaction for Series B Convertible Preferred Stock ("Series B Preferred"): sec.gov The 8-K (12/02/97) concerning Fletcher International Limited and a revision on the Series A Convertible Preferred Stock (the "A Preferred Stock") originally issued in August: sec.gov A filing on 12/03/97 appears to be a revision to the "poison pill" provisions: sec.gov The above documents (and others) can all be seen at the Edgar site: sec.gov I hope this can help with needed data. Mark